1 / 6
Laboratory Research Material
GLP2-T 5mg
- Compound
- GLP2-T
- Amount per vial
- 5 mg
- Form
- Lyophilized powder
- Packaging
- 1 × 3 mL vial, boxed
- Shipping
- FedEx 2DayShips from the U.S. Estimated arrival2 business days after dispatchWeekday dispatch · 4 p.m. ET cutoff
Delivery details
Estimated for in-stock orders using FedEx 2Day. Weekends and FedEx closures are excluded. Holiday pickups, destination and carrier delays can affect arrival. Alaska and Hawaii may take longer.
Free U.S. shipping on orders $199+
Important
Research Use Notice
All articles and product information provided on this website are for informational and educational purposes only. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.
Product Documentation
Details, specifications, and reviews
Description
GLP2-T 5 mg (tirzepatide) research material
Buy Tirzepatide 5 mg for laboratory research, listed in this catalog as GLP2-T. It is supplied as lyophilized powder in one boxed 3 mL vial. The original laboratory report links the catalog label to the scientific name.
Compare the available vial sizes
Other presentations in this family are GLP2-T 10 mg, GLP2-T 15 mg, GLP2-T 30 mg. These options change the labeled quantity; choose the amount required for the planned laboratory work and check the records attached to the selected presentation.
GLP2-T is a catalog name for tirzepatide, not native glucagon-like peptide-2. Dual-receptor activity refers to GIP and GLP-1 receptors; it does not mean the vial contains two separately blended peptides.
GIP and GLP-1 receptor research
Coskun and colleagues characterized LY3298176, the development identifier for tirzepatide, using signaling and functional assays in cells expressing incretin receptors. Their cAMP measurements examined GIP and GLP-1 receptor responses to a defined modified peptide.
The published findings concern the authors’ study material and experimental conditions. They provide research context, not certification of this commercial lot, instructions for use or evidence of clinical equivalence.
When comparing a method with the supplied material, check the specified chemical form and modifications. Receptor activity, chromatographic purity and vial content answer separate questions.
Batch documentation and handling
Open COA & Documents and match the product and lot. Read the methods and reported identity, purity and measured content separately. A name or reference formula does not establish an unreported counterion or complete formulation.
The 5 mg value is the labeled amount of material; the 3 mL value is container capacity. Neither specifies a liquid concentration. Use applicable product records and laboratory procedures for storage and preparation.
Additional information
| CAS No. | 2023788-19-2 (tirzepatide reference compound) |
|---|---|
| Purity | ≥99% |
| Molecular Formula | C225H348N48O68 — reference molecule; excludes counterions and fillers |
| Molecular Weight | Approx. 4813 g/mol — reference molecule; excludes counterions and fillers |
| Synthesis | Solid-phase synthesis |
| Format | Lyophilized powder |
| Solubility | Soluble in water or 1% acetic acid |
| Stability & Storage | Stable for up to 24 months at -20°C. |
| Applications | In-vitro assay research, compound characterization, analytical method development |
| Appearance | White lyophilized powder |
| Shipping Conditions | Shipped at ambient temperature; once received, store at -20°C |
| Regulatory/Compliance | Produced in compliance with cGMP guidelines |
| Safety Information | Refer to provided MSDS |
Independent lot testing
GLP2-T 5mg Certificate of Analysis
This product has featured batch-specific third-party laboratory documentation. The Pure Lab Peptides summary presents selected source-report fields in a consistent format; the linked original laboratory report controls if any information differs.
- Lot number
- 99726
- Report number
- IF-824-QSA-TR006-BTL26955-46
- Date tested
- July 15, 2026
- Reported purity
- 99.6%
- Labeled content
- 5 mg
Product documents
Product information and laboratory resources. For lot-specific results, use the COA above.
Product & packaging information
Labeled amount, physical form and packaging for GLP2-T 5mg.
Revision 0.4 · 2026-10-05Download PDFLaboratory handling guide
General guidance for applicable lyophilized research materials. Not a product-specific SDS.
Revision 1.0 · 2026-09-22Download PDFGeneral guides & resources
Reading a COA & Verifying Your Lot
PDF · Revision 1.0Receiving, Storage & Traceability Record
PDF · Revision 1.0Research Use & Documentation Scope
PDF · Revision 1.0Only logged in customers who have purchased this product may leave a review.
Need Assistance?
Questions about product documentation?
Our support team can assist with product records, lot information, order questions, and certificate verification.

There are no reviews yet.